JBIO - Jade Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$47.83
DETAILS
HIGH:
$55.00
LOW:
$45.00
MEDIAN:
$47.00
CONSENSUS:
$47.83
UPSIDE:
232.38%
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0.0 | 0 | 0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross Profit | (0.0) | 0 | 0 | 0 | (0.0) | (0.0) | 0 | (0.0) | (0.0) | (0.0) | (0.0) |
| Operating Expenses | |||||||||||
| R&D Expenses | 36.1 | 28.5 | 22.0 | 22.5 | 0 | 1.5 | 13.6 | 21.2 | 20.1 | 17.8 | 16.9 |
| SG&A Expenses | 7.4 | 6.4 | 5.4 | 5.2 | 3.4 | 4.9 | 1.4 | 4.9 | 4.5 | 4.2 | 4.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 43.4 | 35.0 | 27.4 | 27.8 | 3.4 | 6.4 | 15.0 | 26.1 | 24.6 | 22.0 | 21.3 |
| Operating Income | |||||||||||
| Operating Income | (43.4) | (35.0) | (27.4) | (27.8) | (3.4) | (6.4) | (15.0) | (26.2) | (24.6) | (22.1) | (21.4) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 3.1 | 3.1 | 2.3 | 1.8 | 0.9 | 1.0 | 0.4 | 1.4 | 1.4 | 1.7 | 1.8 |
| Profitability | |||||||||||
| EBITDA | (40.3) | (31.9) | (25.2) | (32.1) | 20.9 | (5.4) | (16.3) | (24.7) | (23.2) | (20.3) | (19.5) |
| EBIT | (40.4) | (31.9) | (25.2) | (32.1) | (2.5) | (5.4) | (16.3) | (24.8) | (23.2) | (20.4) | (19.6) |
| Income Before Tax | (40.4) | (31.9) | (25.2) | (32.1) | (2.5) | (5.4) | (16.3) | (24.8) | (23.2) | (20.4) | (19.6) |
| Income Tax Expense | 0.0 | 0.1 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0.1 | 0 |
| Net Income | (40.4) | (31.9) | (25.2) | (32.1) | (2.5) | (5.4) | (16.3) | (24.8) | (23.2) | (20.4) | (19.6) |
| Per Share Data | |||||||||||
| EPS (Basic) | -0.70 | -0.65 | -0.64 | -1.13 | -3.04 | -6.56 | -5.16 | -30.15 | -29.20 | -25.80 | -24.77 |
| EPS (Diluted) | -0.70 | -0.65 | -0.64 | -1.13 | -3.04 | -6.56 | -5.16 | -30.15 | -29.20 | -25.80 | -24.77 |
| Shares Outstanding | 57.8 | 49.3 | 39.6 | 28.4 | 0.8 | 0.8 | 3.2 | 0.8 | 0.8 | 0.8 | 0.8 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||
| Cash & Cash Equivalents | 107.2 | 55.1 | 88.4 | 50.1 | 220.9 | 44.2 | 33.8 | 31.1 | 31.1 | 9.1 | 23.5 | 32.2 |
| Short-Term Investments | 354.0 | 256.2 | 247.7 | 148.8 | 0 | 32.0 | 44.9 | 57.6 | 73.1 | 90.2 | 98.9 | 103.0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 10.0 | 7.2 | 0 | 2.5 | 0 | 0.8 | 0.8 | 0.9 | 0.5 | 0.3 | 0.2 | 0.6 |
| Total Current Assets | 471.3 | 318.5 | 336.2 | 201.4 | 223.0 | 77.4 | 80.1 | 90.6 | 110.8 | 103.2 | 124.2 | 137.6 |
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment | 0.8 | 0.8 | 0 | 0.9 | 0.9 | 0.2 | 0.2 | 0.3 | 0.9 | 1.0 | 0.9 | 1.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.1 | 0.1 | 13.6 | 0.2 | 0.1 | (0.0) | (0.0) | 0.1 | 0.1 | 2.6 | 2.3 | 2.2 |
| Total Non-Current Assets | 0.9 | 0.9 | 13.6 | 1.1 | 1.0 | 0.2 | 0.2 | 0.4 | 0.9 | 3.6 | 3.2 | 3.3 |
| Total Assets | 472.1 | 319.4 | 349.8 | 202.4 | 224.0 | 77.5 | 80.3 | 91.0 | 111.7 | 106.8 | 127.4 | 140.9 |
| Current Liabilities | ||||||||||||
| Account Payables | 6.6 | 4.0 | 2.2 | 1.4 | 7.6 | 0.1 | 0.2 | 0.9 | 4.2 | 3.3 | 2.4 | 3.5 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 21.1 | 15.6 | 3.3 | 8.1 | 5.3 | 0.4 | 0.3 | 5.0 | 9.7 | 10.4 | 10.5 | 8.1 |
| Total Current Liabilities | 31.6 | 22.3 | 16.5 | 22.4 | 21.6 | 2.4 | 3.8 | 10.3 | 17.0 | 15.5 | 17.6 | 14.7 |
| Non-Current Liabilities | ||||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Total Non-Current Liabilities | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 | 0.3 | 0.4 |
| Total Liabilities | 32.2 | 23.0 | 17.3 | 23.1 | 22.4 | 2.5 | 3.9 | 10.5 | 17.3 | 15.9 | 18.0 | 15.2 |
| Stockholders' Equity | ||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (270.5) | (214.8) | (174.4) | (142.5) | (117.3) | (235.6) | (233.1) | (227.6) | (211.4) | (186.6) | (163.4) | (143.0) |
| Accumulated Other Comprehensive Income | (0.7) | (0.3) | 0.1 | 0.0 | (0.0) | 0.1 | 0.1 | 0.2 | (0.1) | (0.0) | 0.2 | (0.2) |
| Total Stockholders' Equity | 439.9 | 296.5 | 332.5 | 179.3 | 201.6 | 75.0 | 76.4 | 80.5 | 94.4 | 90.9 | 109.5 | 125.7 |
| Total Liabilities & Equity | 472.1 | 319.4 | 349.8 | 202.4 | 224.0 | 77.5 | 80.3 | 91.0 | 111.7 | 106.8 | 127.4 | 140.9 |
| Debt Metrics | ||||||||||||
| Total Debt | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.3 | 0.4 | 0.5 | 0.7 | 0.8 | 0.7 | 0.8 |
| Net Debt | (106.6) | (54.4) | (87.7) | (49.4) | (220.2) | (43.9) | (33.3) | (30.6) | (30.4) | (8.3) | (22.8) | (31.4) |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | (55.8) | (40.4) | (31.9) | (25.2) | (32.1) | (38.2) | (30.1) | (16.9) | (24.8) | (23.2) | (20.4) | (19.6) |
| Depreciation & Amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 23.4 | 0.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Stock-Based Compensation | 0 | 7.4 | 9.4 | 4.3 | 3.9 | 2.4 | 1.2 | 0.0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (1.2) | 9.3 | (10.5) | (1.1) | 1.8 | 1.6 | 2.2 | 8.3 | 1.1 | (4.0) | 3.3 | 1.5 |
| Other Non-Cash Items | 13.3 | (0.5) | (0.6) | (0.2) | 6.2 | (8.0) | 10.9 | 1.7 | 3.2 | 3.4 | 2.3 | 2.4 |
| Operating Cash Flow | (43.7) | (24.1) | (33.6) | (22.1) | (20.2) | (18.8) | (15.8) | (6.8) | (20.4) | (23.7) | (14.8) | (15.6) |
| Investing Activities | ||||||||||||
| Capital Expenditure | 0 | 0 | (0.0) | (0.1) | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (142.3) | (73.9) | (112.6) | 0 | 0 | 0 | 0 | 0 | 0 | (14.8) | (27.8) | (47.8) |
| Sales/Maturities of Investments | 44.7 | 65.4 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 23.6 | 33.5 | 34.8 |
| Other Investing Activities | 0 | 0 | 14.4 | (148.7) | (0.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (97.6) | (8.5) | (98.2) | (148.7) | (0.1) | 0 | 0 | 0 | 18 | 8.8 | 5.6 | (13.1) |
| Financing Activities | ||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 192.0 | (0.8) | 171.5 | 0 | 191.3 | (0.7) | (2.8) | (0.2) | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 193.5 | (0.8) | 170.2 | 0 | 191.3 | (0.7) | (2.8) | 94.8 | 24.4 | 0.5 | 0.5 | 0.0 |
| Cash Position | ||||||||||||
| Net Change in Cash | 52.2 | (33.4) | 38.3 | (170.8) | 171.0 | (19.5) | (18.6) | 88.0 | 21.9 | (14.4) | (8.7) | (28.7) |
| Cash at Beginning | 55.1 | 88.4 | 50.1 | 220.9 | 49.9 | 69.4 | 88.0 | 0 | 9.1 | 23.5 | 32.2 | 60.9 |
| Cash at End | 107.2 | 55.1 | 88.4 | 50.1 | 220.9 | 49.9 | 69.4 | 88.0 | 31.1 | 9.1 | 23.5 | 32.2 |
| Free Cash Flow | (43.7) | (24.1) | (33.7) | (22.2) | (20.2) | (18.8) | (15.8) | (6.8) | (20.4) | (23.7) | (14.9) | (15.6) |
| Key Metrics | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Gross Profit | (0.0) | 0 | 0 | 0 | (0.0) | (0.0) | 0 | (0.0) | (0.0) | (0.0) | (0.0) | |
| Operating Income | (43.4) | (35.0) | (27.4) | (27.8) | (3.4) | (6.4) | (15.0) | (26.2) | (24.6) | (22.1) | (21.4) | |
| Net Income | (40.4) | (31.9) | (25.2) | (32.1) | (2.5) | (5.4) | (16.3) | (24.8) | (23.2) | (20.4) | (19.6) | |
| EPS (Diluted) | -0.70 | -0.65 | -0.64 | -1.13 | -3.04 | -6.56 | -5.16 | -30.15 | -29.20 | -25.80 | -24.77 | |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 107.2 | 55.1 | 88.4 | 50.1 | 220.9 | 44.2 | 33.8 | 31.1 | 31.1 | 9.1 | 23.5 | 32.2 |
| Total Assets | 472.1 | 319.4 | 349.8 | 202.4 | 224.0 | 77.5 | 80.3 | 91.0 | 111.7 | 106.8 | 127.4 | 140.9 |
| Total Debt | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.3 | 0.4 | 0.5 | 0.7 | 0.8 | 0.7 | 0.8 |
| Stockholders' Equity | 439.9 | 296.5 | 332.5 | 179.3 | 201.6 | 75.0 | 76.4 | 80.5 | 94.4 | 90.9 | 109.5 | 125.7 |
| Cash Flow | ||||||||||||
| Operating Cash Flow | (43.7) | (24.1) | (33.6) | (22.1) | (20.2) | (18.8) | (15.8) | (6.8) | (20.4) | (23.7) | (14.8) | (15.6) |
| Capital Expenditure | 0 | 0 | (0.0) | (0.1) | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.0) |
| Free Cash Flow | (43.7) | (24.1) | (33.7) | (22.2) | (20.2) | (18.8) | (15.8) | (6.8) | (20.4) | (23.7) | (14.9) | (15.6) |